Wealthspire Advisors, LLC Provention Bio, Inc. Transaction History

Wealthspire Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $159,612 - $234,906	-28,200 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$10.12 - $19.45 $151,800 - $291,750	-15,000 Reduced 34.72%	28,200 $296,000
Q4 2020 Feb 16, 2021	BUY	$11.79 - $18.94 $509,327 - $818,208	43,200 New	43,200 $732,000
Q2 2020 Aug 14, 2020	SELL	$7.81 - $17.0 $624,800 - $1.36 Million	-80,000 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$5.42 - $17.75 $433,600 - $1.42 Million	80,000 New	80,000 $736,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthspire Advisors, LLC with notifications on news.